Search

everythinglearnresearchcommunity

for

Search:↓

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

The document concludes that proper recognition and treatment of skin appendage disorders are important for management.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Dermatological drugs and cosmetics can cause serious side effects like cancer, allergies, and heart issues.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Cataract surgery guidelines vary across Europe, and generic finasteride sales for hair loss have grown due to pill splitting.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

People with HIV and low T cell counts have more hair and scalp problems.

Cannabinoids may help some skin conditions but more research is needed.

Exosomes are important for skin treatments and hair growth but need more research for safe and effective use.

Treating chronic hand eczema costs about the same in statutory and occupational health insurances in Germany, but work-related cases may lead to higher indirect costs due to longer work absences.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

Finasteride increases hair count and improves hair growth with low risk of side effects.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.